Endosomal and lysosomal lumen

The endosomal and lysosomal lumen refers to the internal acidic environment of the organelles involved in the endocytic and autophagic pathways. This compartment is characterized by a high concentration of acid hydrolases and a low pH maintained by vacuolar-type H+-ATPases, which is vital for the degradation of proteins, lipids, and complex carbohydrates (NCBI Bookshelf, 2023). While not a single protein target, it is a focal point for treating lysosomal storage disorders through enzyme replacement therapies and for drugs that exploit its acidity. Lysosomotropic agents, such as hydroxychloroquine, selectively accumulate in this space due to the pH gradient, which can inhibit viral entry or modulate immune responses (PubMed, 2020). Dysfunction within this lumen, such as pH imbalance or substrate accumulation, is a hallmark of various neurodegenerative diseases and certain cancers (Nature Reviews Molecular Cell Biology, 2019). Furthermore, the lumen serves as a critical site for the activation of prodrugs and the release of cargo from antibody-drug conjugates. Understanding the luminal environment is crucial for the design of nanomedicines and targeted drug delivery systems that require triggered release in acidic conditions (Journal of Controlled Release, 2021).

Other names

Endolysosomal lumenLysosomal interiorEndosomal spaceVacuolar lumen

Drugs typically act by accumulating within the acidic lumen via lysosomotropism, replacing deficient enzymes through enzyme replacement therapy, or modulating luminal pH to restore homeostatic function.